blue cross blue shield cover glp-1 to stop covering popular weight-loss drugs Life - New Year, New
Description
2023 Nov;176(11):JC129
The catches: it is built around GLP-1s (other medications are bare custom entries, with no reconstitution or vial tooling), and the analytical features (estimated medication-level curves, Apple Health sync) sit behind premium from $9.99/mo
doi:10.1007/s00125-010-1896-4 29
Now it's being studied for MS, and psoriatic arthritis, and other autoimmune diseases
J., Joyce D., Shah S
All of this is what allows GLP-1 receptor agonists to help treat type 2 diabetes
